BSE filing, NSE: THEMISMED. Summary written from the filing by ALFA Finder's alert engine.
Themis Medicare Ltd: key numbers
- Share price
- ₹94.83
- Market cap
- ₹873.4 Cr
- Revenue (annual)
- ₹342.2 Cr
- Net profit (annual)
- ₹1.14 Cr
- P/E (TTM)
- 21.9×Sector 48.7×
- Promoter holding
- 67.11%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Themis Medicare Ltd
All →Themis Medicare Share Pledge
Promoter Vividhmargi pledged 15 lakh Themis Medicare shares for a Rs 135 Crore borrowing. Total encumbrance rises to 4.89% of capital.
- Value
- ₹135.0 Cr
Themis Medicare Management Change
Themis Medicare proposes re-appointing Independent Director Bhaskar Vemban Iyer for a second five-year term from 12 November 2026. Postal ballot notice dispatched to members seeking approval.
Themis Medicare Annual General Meeting
Themis Medicare seeks shareholder approval via postal ballot for a special resolution re-appointing Mr. Bhaskar Iyer as Independent Director for a second five-year term. Remote e-voting runs 24 October to 22 November 2026.
Themis Medicare Other Announcement
Themis Medicare Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI Regulation 31(1)(b).
Themis Medicare Credit Rating
CARE Ratings downgraded Themis Medicare's long-term and short-term bank facility ratings. The downgrade reflects deteriorating profitability, heightened competition, and weak debt coverage indicators.
Themis Medicare Other Announcement
Themis Medicare Ltd filed its quarterly shareholding pattern for the period ended June 30, 2026. This is a routine regulatory disclosure under Regulation 31.
Other board meeting date announcements
All →Liotech Industries Board Meeting Date
Liotech Industries will hold a board meeting on November 4, 2026 to consider standalone unaudited results for the half year ended September 30, 2026. The trading window closes from October 1 until 48 hours after the results are declared.
Organic Coatings Board Meeting Date
Organic Coatings will hold a board meeting on November 5, 2026 to consider unaudited Q2 and half-year results. The trading window closes from October 1 until 48 hours after the results are made public.
Oswal Green Tech Board Meeting Date
Oswal Greentech will hold a board meeting on November 4, 2026 to approve unaudited Q2/H1 results. The filing also reminds that the trading window stays closed from October 1 until 48 hours after results.
Kronox Lab Sciences Board Meeting Date
Kronox Lab Sciences schedules a November 5, 2026 board meeting to consider unaudited half-yearly standalone results. Trading window closes October 1 to November 7, 2026.
Oswal Agro Mills Board Meeting Date
Oswal Agro Mills schedules a November 4, 2026 board meeting to approve Q2/H1 unaudited results and declare an interim dividend for FY 2026-27. The filing is a prior intimation of a future meeting with agenda items still proposed.
CLIO Infotech Board Meeting Date
Clio Infotech will hold a board meeting on 04 Nov 2026 to consider unaudited financial results for the quarter and half year ended 30 September 2026. Trading window closes from 01 Oct 2026 until 48 hours after results.